Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-11-21 5:00 pm Purchase | 2022-11-20 | 13D | CYCLERION THERAPEUTICS INC CYCN | Peter M. Hecht | 210,003 9.200% | 30,170 (+16.78%) | Filing History |
| 2022-10-21 5:13 pm Unchanged | 2022-10-21 | 13D | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 357,880 16.500% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:41 pm Purchase | 2021-12-31 | 13G | CYCLERION THERAPEUTICS INC CYCN | Slate Path Capital LP | 357,880 16.490% | 48,077 (+15.52%) | Filing History |
| 2022-02-11 06:35 am Purchase | 2021-12-31 | 13G | CYCLERION THERAPEUTICS INC CYCN | Artal International S.C.A. | 138,956 6.400% | 48,077 (+52.90%) | Filing History |
| 2022-02-09 09:31 am Purchase | 2021-12-31 | 13G | CYCLERION THERAPEUTICS INC CYCN | MFN Partners LP | 169,461 7.800% | 169,461 (New Position) | Filing History |
| 2022-02-09 09:11 am Sale | 2022-02-08 | 13G | CYCLERION THERAPEUTICS INC CYCN | FMR LLC | 130,871 6.042% | -5,115 (-3.76%) | Filing History |
| 2021-06-07 5:21 pm Purchase | 2021-06-03 | 13D | CYCLERION THERAPEUTICS INC CYCN | Peter M. Hecht | 179,833 8.600% | 41,158 (+29.68%) | Filing History |
| 2021-05-14 4:56 pm Purchase | 2021-05-04 | 13D | CYCLERION THERAPEUTICS INC CYCN | Peter M. Hecht | 138,675 7.800% | 138,675 (New Position) | Filing History |